查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1717774

空间基因组学和转录组学市场（按产品、定序方法、应用和最终用户）—2025-2030 年全球预测

Spatial Genomics & Transcriptomics Market by Product, Sequencing Method, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

空间基因组学和转录组学市场预计在 2023 年价值 10.5 亿美元，在 2024 年达到 11.8 亿美元，并以 12.35% 的复合年增长率增长，到 2030 年达到 23.8 亿美元。

主要市场统计数据
基准年2023年 10.5亿美元
预计2024年 11.8亿美元
预测年份 2030 23.8亿美元
复合年增长率（%） 12.35%

空间基因组学和转录组学已成为生命科学的关键领域，重新定义了我们对细胞功能和组织结构的理解。成像、定序和计算数据分析的进步汇聚在一起，创造了一门变革性学科，其中空间背景在阐明复杂的生物现像中发挥关键作用。这项新模式正在刺激投资增加、扩大研究视野并鼓励专家之间的跨学科合作。在技​​术突破和对人体和疾病机制的深入了解的不断追求的推动下，该领域正在迅速发展成为精准医疗的基石。目前的情况为诊断检测、药物发现和标靶治疗的创新提供了良好的机会，为全面探索其对医疗保健和研究的影响奠定了基础。随着该领域的加速发展，研究人员和决策者必须掌握既定原则和新兴趋势，以发挥空间生物学的潜力。

改变空间基因组学和转录组学市场

近年来，空间基因组学和转录组学领域发生了变革性的变化。技术进步促进了新的定序平台和成像技术的发展，提供了前所未有的解析度和效率。人们正在从传统的批量分析转向单细胞和基于空间的研究，这正在重新定义实验设计和数据解释。这些变化体现在跨学科合作推动的快速技术创新。计算工具和数据分析的进步使研究人员能够破解组织内的复杂空间关係，增强我们理解细胞网络内基因表现的空间编配的能力。这种动态环境预示着一个新时代的到来，精准技术不仅将加强研究，还将推动个人化治疗和诊断的发展。公司、学术团体和临床研究机构正在加大对这些方法的投资，以在竞争激烈的研究领域中保持领先地位，因此产业相关人员必须从策略上适应这些变革趋势。

关键细分洞察

对空间基因组学和转录组学细分框架的详细分析揭示了由多种因素塑造的多面向市场模式。以产品维度为关键轴，将市场分解为耗材、设备和软体。在检测试剂套件和试剂的背景下对耗材部分进行了研究，在高精度分子工具需求的推动下，耗材部分呈现强劲增长。同时，设备部分包括尖端显微镜和定序平台，它们对于实现空间分析的高解析度至关重要。此外，数据分析平台和视觉化工具等软体解决方案在解释复杂数据集方面发挥着至关重要的作用。原位定序、多重抗误差萤光原位杂合技术、连续式萤光原位杂合技术、Slide-seq 和空间转录组学等方法提供了独特的能力和分析可能性。在考虑应用时，研究重点包括癌症研究（包括肿瘤学分析和肿瘤微环境分析的详细评估）到发育生物学、药物发现、免疫学和神经病学。例如，在药物研发中，生物标记分析和治疗标靶识别已成为关键的研究驱动力。此外，按最终用户细分，可以发现受众范围广泛，从细分为生物部门和基因组学中心等专门单位的学术研究机构，到临床研究机构、製药公司、生物技术公司和研究实验室（包括核心设施和私人实验室）。综合起来，这些细分揭示了市场成熟度的水平，每个细分都为研究、技术和目标应用的生态系统做出了贡献。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 慢性病盛行率的上升推动了先进空间基因组解决方案的需求。
      • 空间基因组学和转录组学在个人化医疗的应用日益增多
      • 早期检测和诊断的重要性日益增加，推动了空间基因组学的创新
    • 限制因素
      • 在合理时限内取得高解析度空间资料的局限性
    • 机会
      • 显微镜和成像技术的进步提高了基因组学研究的空间解析度和精度。
      • 增加基因组学调查的资金将刺激空间转录组学研究的发展
    • 任务
      • 基因和单细胞定序的报销差异和不确定性
  • 市场区隔分析
    • 产品：高通量和高准确度正在推动实验室中检测试剂套件的使用增加
    • 定序方法：使用具有高解析度基因表现空间图的幻灯片定序提供了重要的见解。
    • 应用：采用空间基因组学加速药物发现与开发
    • 最终用户：优先考虑临床研究机构，提高临床试验的准确性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 空间基因体学和转录组学市场（按产品）

  • 耗材
    • 检测试剂套件
    • 试剂
  • 装置
    • 显微镜
    • 定序平台
  • 软体
    • 数据分析平台
    • 视觉化工具

7. 空间基因体学和转录组学市场（按定序方法）

  • 原位定序
  • 多重误差稳健萤光杂合反应
  • 常规萤光原位杂合反应
  • 幻灯片序列
  • 空间转录组学

8. 空间基因体学和转录组学市场（按应用）

  • 癌症研究
    • 肿瘤学分析
    • 肿瘤微环境分析
  • 发育生物学
  • 药物研发
    • 生物标记分析
    • 确定治疗目标
  • 免疫学
  • 神经病学

9. 空间基因体学和转录组学市场（按最终用户）

  • 学术研究所
    • 生物系
    • 基因组学中心
  • 临床研究所
  • 製药和生物技术公司
  • 研究部门
    • 核心设施
    • 私人实验室

10.美洲空间基因体学和转录组学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

11. 亚太地区空间基因体学与转录组学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12. 欧洲、中东和非洲太空基因体学和转录组学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023年市场占有率分析
  • 2023年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Akoya Biosciences, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Bruker Corporation
  • Carl Zeiss AG
  • Danaher Corporation
  • Evident Corporation
  • Illumina, Inc.
  • Indica Labs, Inc.
  • Ionpath, Inc.
  • Merck KGaA
  • Parse Biosciences
  • PerkinElmer, Inc.
  • RareCyte, Inc.
  • Rebus Biosystems, Inc.
  • Resolve Biosciences GmbH.
  • S2 Genomics, Inc.
  • Seven Bridges Genomics
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
  • Ultivue, Inc.
  • Vizgen Inc.
Product Code: MRR-F611BFBC5D35

The Spatial Genomics & Transcriptomics Market was valued at USD 1.05 billion in 2023 and is projected to grow to USD 1.18 billion in 2024, with a CAGR of 12.35%, reaching USD 2.38 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 1.05 billion
Estimated Year [2024] USD 1.18 billion
Forecast Year [2030] USD 2.38 billion
CAGR (%) 12.35%

Spatial genomics and transcriptomics have emerged as pivotal areas in life sciences, redefining our understanding of cellular function and tissue architecture. Advances in imaging, sequencing, and computational data analysis have converged to create a transformative discipline, where spatial context plays a critical role in elucidating complex biological phenomena. This new paradigm has fueled increased investments, broadened research horizons, and inspired cross-disciplinary collaboration among experts. Driven by technological breakthroughs and an insatiable quest for deeper insights into the human body and disease mechanisms, this field is rapidly evolving into a cornerstone of precision medicine. The present landscape offers promising opportunities for innovation in diagnostic assays, drug discovery, and targeted therapies, setting the stage for a comprehensive exploration of its impact on medicine and research. As the field accelerates, researchers and decision-makers must navigate both established principles and emerging trends to capitalize on the potential of spatial biology.

Transformative Shifts in the Landscape

Recent years have witnessed transformative shifts within the spatial genomics and transcriptomics arena. Technological evolution has spurred the development of new sequencing platforms and imaging techniques that offer unprecedented resolution and efficiency. An ongoing transition is underway from traditional bulk analyses to single-cell and spatially informed studies, a shift that is redefining experimental design and data interpretation. These changes are underscored by rapid innovation driven by interdisciplinary collaboration. Advances in computational tools and data analytics are now enabling researchers to decode complex spatial relationships in tissues, thus enhancing our ability to understand the spatial orchestration of gene expression within cellular networks. This dynamic environment is heralding a new era where precision techniques not only bolster research but also foster the development of personalized therapies and diagnostics. Enterprises, academicians, and clinical research organizations are increasingly investing in these methodologies to stay ahead in a competitive research landscape, making it imperative for industry stakeholders to adapt strategically to these transformative trends.

Key Segmentation Insights

A detailed analysis of the segmentation framework in spatial genomics and transcriptomics reveals a multi-faceted market landscape shaped by diverse factors. With the product dimension as a crucial axis, the market dissects into consumables, instruments, and software. The consumables segment, studied in the context of assay kits and reagents, demonstrates robust growth driven by demand for high-precision molecular tools. In parallel, the instruments segment encompasses state-of-the-art microscopes and sequencing platforms that are essential for achieving high resolution in spatial analysis. Additionally, software solutions, including data analysis platforms and visualization tools, play an indispensable role in interpreting complex datasets. The evolution of sequencing methodologies further enriches segmentation; approaches such as in situ sequencing, multiplexed error-robust fluorescence in situ hybridization, sequential fluorescence in situ hybridization, Slide-seq, and spatial transcriptomics offer distinct capabilities and analysis potential. When considering applications, research focuses span from cancer research-which includes detailed evaluations in oncology profiling and tumor microenvironment analysis-to developmental biology, drug discovery, immunology, and neurology. In drug discovery, for example, biomarker analysis and therapeutic target identification are emerging as key research drivers. Furthermore, segmentation by end-user highlights audiences ranging from academic research institutions, subdivided into specialized bodies such as biology departments and genomics centers, to clinical research organizations, pharmaceutical and biotechnology companies, and research laboratories that include core facilities along with private labs. Collectively, these segmentation insights underline the level of sophistication present in the market, where each segment contributes to an interwoven ecosystem of research, technology, and targeted application.

Based on Product, market is studied across Consumables, Instruments, and Software. The Consumables is further studied across Assay Kits and Reagents. The Instruments is further studied across Microscopes and Sequencing Platforms. The Software is further studied across Data Analysis Platforms and Visualization Tools.

Based on Sequencing Method, market is studied across In Situ Sequencing, Multiplexed Error-Robust Fluorescence In Situ Hybridization, Sequential Fluorescence In Situ Hybridization, Slide-seq, and Spatial Transcriptomics.

Based on Application, market is studied across Cancer Research, Developmental Biology, Drug Discovery, Immunology, and Neurology. The Cancer Research is further studied across Oncology Profiling and Tumor Microenvironment Analysis. The Drug Discovery is further studied across Biomarker Analysis and Therapeutic Target Identification.

Based on End-User, market is studied across Academic Research Institutions, Clinical Research Organizations, Pharmaceutical & Biotechnology Companies, and Research Laboratories. The Academic Research Institutions is further studied across Biology Departments and Genomics Centers. The Research Laboratories is further studied across Core Facilities and Private Labs.

Key Regional Insights

Geographical trends play a significant role in shaping the spatial genomics and transcriptomics market. In the Americas, a robust network of leading research institutions and a strong focus on precision medicine are driving innovations and adoption. The Europe, Middle East & Africa region sees a confluence of traditional academic excellence and rapidly expanding industrial research, where regulatory frameworks and cross-border collaborations are facilitating advanced studies. Meanwhile, in the Asia-Pacific, dynamic economic growth and substantial investments in biotechnology are fueling rapid market expansion, making it a focal point for transformative research initiatives. These regions collectively provide a heterogeneous landscape of research capabilities and investment opportunities, representing both mature markets and fast-growing territories within the global spatial biology arena. As these regions continue to evolve, strategic geographical insights are essential for aligning research investments with local expertise and global trends.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights

Industry leaders are spearheading innovation in spatial genomics and transcriptomics through strategic investments in research and technology development. Prominent companies such as 10x Genomics, Inc. and Agilent Technologies, Inc. are pushing the boundaries by introducing state-of-the-art instruments and consumables that enable unparalleled analytical precision. Akoya Biosciences, Inc. and Becton, Dickinson and Company have become key players by offering comprehensive imaging and diagnostic solutions, while Bio-Rad Laboratories, Inc. and Bio-Techne Corporation continue to enrich the market with high-quality assay kits and reagents. Bruker Corporation and Carl Zeiss AG consolidate their positions by delivering advanced microscopy systems, and Danaher Corporation along with Evident Corporation are renowned for their robust contribution to cutting-edge analytical tools. Illumina, Inc. and Indica Labs, Inc. have set benchmarks in high-throughput sequencing and data management, and innovative solutions from Ionpath, Inc. and Merck KGaA further highlight the competitive spirit in the market. Emerging leaders such as Parse Biosciences, PerkinElmer, Inc., RareCyte, Inc., Rebus Biosystems, Inc., Resolve Biosciences GmbH., S2 Genomics, Inc., Seven Bridges Genomics, Standard BioTools Inc., Thermo Fisher Scientific Inc., Ultivue, Inc., and Vizgen Inc. drive the competitive landscape by constantly exploring new technological frontiers. These companies collectively underscore the market's diverse and competitive ecosystem, where strategic partnerships and continuous innovation are keys to maintaining leadership in this rapidly evolving field.

The report delves into recent significant developments in the Spatial Genomics & Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Akoya Biosciences, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Bruker Corporation, Carl Zeiss AG, Danaher Corporation, Evident Corporation, Illumina, Inc., Indica Labs, Inc., Ionpath, Inc., Merck KGaA, Parse Biosciences, PerkinElmer, Inc., RareCyte, Inc., Rebus Biosystems, Inc., Resolve Biosciences GmbH., S2 Genomics, Inc., Seven Bridges Genomics, Standard BioTools Inc., Thermo Fisher Scientific Inc., Ultivue, Inc., and Vizgen Inc.. Actionable Recommendations for Industry Leaders

Industry leaders should invest in robust cross-disciplinary research collaborations and foster technology partnerships to secure a competitive edge in the spatial genomics and transcriptomics landscape. It is essential to channel resources into state-of-the-art instrumentation and advanced computational analytics, ensuring that new methodologies drive both speed and accuracy in research efforts. Companies must establish agile operational frameworks that allow for rapid adaptation to technological breakthroughs and evolving market paradigms. Auditing current research portfolios and aligning them with emerging trends will enable a seamless transition into areas with high growth potential, particularly in personalized medicine and precision diagnostic platforms. A proactive stance on regulatory compliance and intellectual property management is critical in maintaining market integrity and safeguarding innovations. Furthermore, nurturing talent through strategic training programs and in-house research initiatives will not only drive internal innovation but also solidify partnerships with external academic and clinical institutions. Overall, this multi-pronged approach will position industry stakeholders to successfully navigate the evolving market dynamics and fully capitalize on the transformative potential of spatial genomics and transcriptomics.

Conclusion: A Vision for Future Growth

In conclusion, the landscape of spatial genomics and transcriptomics is poised to unlock unprecedented research opportunities and applications across medicine and biology. The integration of innovative instruments with advanced software solutions and diverse sequencing methodologies is setting new standards in research precision and diagnostic accuracy. Strategic segmentation by product, sequencing method, application, and end-user highlights a complex yet dynamic market structure that caters to various scientific and healthcare needs. Coupled with significant regional and corporate insights, the stage is set for transformative growth driven by relentless innovation and collaborative ingenuity. The future of spatial genomics stands as a testament to the power of next-generation technologies, offering industry leaders a promising horizon to enhance investments and expand their influence in biomedical research.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases drives demand for advanced spatial genomic solutions
      • 5.1.1.2. Increasing applications of spatial genomics and transcriptomics in personalized medicine
      • 5.1.1.3. Growing emphasis on early detection and diagnosis fueling innovations in spatial genomics
    • 5.1.2. Restraints
      • 5.1.2.1. Limitations in capturing high-resolution spatial data within reasonable timeframes
    • 5.1.3. Opportunities
      • 5.1.3.1. Developments in microscopy and imaging techniques enhancing spatial resolution and accuracy in genomics studies
      • 5.1.3.2. Increased funding for genomics research boosting developments in spatial transcriptomics studies
    • 5.1.4. Challenges
      • 5.1.4.1. Reimbursement inconsistency and uncertainty in gene & single-cell sequencing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing usage for assay kits in laboratories due to their high throughput and accuracy
    • 5.2.2. Sequencing Method: Utilization of slide-seq due to high-resolution spatial maps of gene expression, providing critical insights
    • 5.2.3. Application: Adoption of spatial genomics in accelerating drug discovery and development
    • 5.2.4. End-User: Preference for clinical research organizations enhancing precision in clinical trials
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Spatial Genomics & Transcriptomics Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Assay Kits
    • 6.2.2. Reagents
  • 6.3. Instruments
    • 6.3.1. Microscopes
    • 6.3.2. Sequencing Platforms
  • 6.4. Software
    • 6.4.1. Data Analysis Platforms
    • 6.4.2. Visualization Tools

7. Spatial Genomics & Transcriptomics Market, by Sequencing Method

  • 7.1. Introduction
  • 7.2. In Situ Sequencing
  • 7.3. Multiplexed Error-Robust Fluorescence In Situ Hybridization
  • 7.4. Sequential Fluorescence In Situ Hybridization
  • 7.5. Slide-seq
  • 7.6. Spatial Transcriptomics

8. Spatial Genomics & Transcriptomics Market, by Application

  • 8.1. Introduction
  • 8.2. Cancer Research
    • 8.2.1. Oncology Profiling
    • 8.2.2. Tumor Microenvironment Analysis
  • 8.3. Developmental Biology
  • 8.4. Drug Discovery
    • 8.4.1. Biomarker Analysis
    • 8.4.2. Therapeutic Target Identification
  • 8.5. Immunology
  • 8.6. Neurology

9. Spatial Genomics & Transcriptomics Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Research Institutions
    • 9.2.1. Biology Departments
    • 9.2.2. Genomics Centers
  • 9.3. Clinical Research Organizations
  • 9.4. Pharmaceutical & Biotechnology Companies
  • 9.5. Research Laboratories
    • 9.5.1. Core Facilities
    • 9.5.2. Private Labs

10. Americas Spatial Genomics & Transcriptomics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Spatial Genomics & Transcriptomics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Spatial Genomics & Transcriptomics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Vizgen launch CSP program to broaden single-cell spatial genomics access
    • 13.3.2. Complete Genomics announces exclusive agreement with STOmics spatial transcriptomics and launches spatial Xcellerator grant
    • 13.3.3. Vizgen and Ultivue announce merger to propel innovation in spatial genomics and proteomics
    • 13.3.4. Lunaphore partners with Discovery Life Sciences to bring innovative spatial biology solutions to clinical research
    • 13.3.5. Deerfield proposes acquisition of Singular Genomics to enhance strategic growth in genomics and multiomics technologies
    • 13.3.6. Moleculent secures USD 26 million in series A funding to propel innovations in spatial genomics and transcriptomics
    • 13.3.7. Bruker acquires NanoString spatial biology business to enhance genomic solutions
    • 13.3.8. 10x Genomics launch Visium HD for advanced single cell-scale spatial transcriptome analysis
    • 13.3.9. DNAnexus and Curio Bioscience collaborate to enhance data analysis for spatial transcriptomics projects
    • 13.3.10. Singular Genomics launches G4X spatial sequencer to enhancing multiomic analysis efficiency
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Becton, Dickinson and Company
    • 13.4.2. Agilent Technologies, Inc.
    • 13.4.3. Bruker Corporation
    • 13.4.4. 10x Genomics, Inc.

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Akoya Biosciences, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Bio-Techne Corporation
  • 7. Bruker Corporation
  • 8. Carl Zeiss AG
  • 9. Danaher Corporation
  • 10. Evident Corporation
  • 11. Illumina, Inc.
  • 12. Indica Labs, Inc.
  • 13. Ionpath, Inc.
  • 14. Merck KGaA
  • 15. Parse Biosciences
  • 16. PerkinElmer, Inc.
  • 17. RareCyte, Inc.
  • 18. Rebus Biosystems, Inc.
  • 19. Resolve Biosciences GmbH.
  • 20. S2 Genomics, Inc.
  • 21. Seven Bridges Genomics
  • 22. Standard BioTools Inc.
  • 23. Thermo Fisher Scientific Inc.
  • 24. Ultivue, Inc.
  • 25. Vizgen Inc.

LIST OF FIGURES

  • FIGURE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET MULTI-CURRENCY
  • FIGURE 2. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET MULTI-LANGUAGE
  • FIGURE 3. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET RESEARCH PROCESS
  • FIGURE 4. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY VISUALIZATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IN SITU SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MULTIPLEXED ERROR-ROBUST FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENTIAL FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SLIDE-SEQ, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ONCOLOGY PROFILING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TUMOR MICROENVIRONMENT ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOMARKER ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY THERAPEUTIC TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOLOGY DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY GENOMICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CORE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRIVATE LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 142. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 143. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 148. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 150. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 151. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 153. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 154. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 159. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 161. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 162. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 169. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 170. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 172. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 173. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 180. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 181. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 183. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 184. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 189. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 191. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 192. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 194. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 200. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 202. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 206. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 213. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 214. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 216. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 224. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 228. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 230. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 233. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 235. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 236. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 238. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 239. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 241. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 242. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 243. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 244. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 246. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 247. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 249. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 250. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 252. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 253. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 254. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 255. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 257. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 258. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 260. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 273. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 275. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 276. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 277. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 278. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 280. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 281. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 283. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 284. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 286. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 287. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 288. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 289. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 291. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 292. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 293. EGYPT SPATIAL GENOMICS & TRANS